"A proposed Medicare rule to curb alleged billing abuse in remote patient monitoring has ignited a significant rift among major healthcare players, with integrated health systems fiercely opposing a measure that could disrupt their business models, while others see it as a necessary step to ensure quality care for seniors."
A pivotal proposal by the Centers for Medicare & Medicaid Services (CMS) to reshape how remote patient monitoring (RPM) services are reimbursed has created a stark division within the healthcare industry. The plan, designed to address concerns about billing irregularities and ensure the integrity of RPM services, has drawn sharp opposition from powerful entities like UnitedHealth Group, CVS Health, and Kaiser Permanente. Conversely, insurers such as Humana and the Blue Cross Blue Shield Association have voiced their support for the proposed changes, highlighting a fundamental disagreement over the best approach to regulate a rapidly expanding area of healthcare delivery. This dispute carries significant weight for millions of older adults who rely on RPM to manage chronic conditions, particularly as the crucial Medicare open enrollment period approaches on October 15. The differing stances underscore how the intricate business structures of healthcare organizations can profoundly influence their policy positions, especially when those structures involve both insurance and direct patient care provision.
The core of the controversy lies within CMS’s proposed 2027 physician fee schedule, unveiled on July 14. This proposal seeks to restrict Medicare payments for remote physiologic and therapeutic monitoring exclusively to instances where the clinical staff performing the services are directly employed by the billing practice. This stands in contrast to the current practice, which often involves services contracted out to third-party companies. While the proposal clarifies that these directly employed staff would not need to work on-site, it introduces other requirements, including a mandatory initiating visit before monitoring commences and a reduction in some payment rates. If finalized, these changes are slated to take effect on January 1, 2027.
The integrated nature of businesses like UnitedHealth Group, CVS Health, and Kaiser Permanente is a significant factor in their opposition. These organizations operate not only as insurance providers but also as extensive care delivery networks, encompassing hospitals, clinics, and physician groups. A ban on contracted monitoring staff would directly impact their own employed clinicians and potentially disrupt the operational flow within their comprehensive care systems. CVS, for instance, which owns the insurance giant Aetna, has advocated for Medicare to establish vendor standards rather than implement a blanket ban. Similarly, Kaiser Permanente has articulated that the proposal would "disproportionately impact integrated delivery systems," where the intricate web of employment across different business units means staff from one entity might care for patients managed by another.
UnitedHealth Group’s position is particularly noteworthy given its own recent history with RPM coverage. In 2025, its insurance arm, UnitedHealthcare, initially announced a restrictive policy, limiting RPM coverage to only heart failure and high blood pressure during pregnancy, citing a lack of proven efficacy for other uses. However, this policy was subsequently postponed following significant pushback from healthcare providers, suggesting a sensitivity to the economic and clinical implications of such limitations.
The broader implications of this insurer split are particularly significant for Medicare Advantage members. More than 230 health organizations have collectively warned that the proposed vendor limitations could lead to substantial disruptions in patient care. A coalition estimate suggests that over one million beneficiaries could be affected, though this figure originates from the coalition rather than CMS. The new dimension to this debate is the division among insurers that manage Medicare Advantage plans. According to industry analysts, plans that do not rely heavily on large employed care networks or extensive vendor partnerships may find it easier to support a ban with minimal internal disruption. This suggests that the ultimate impact on a patient’s access to RPM could, in part, be dictated by the ownership structure of their healthcare providers.
While Medicare Advantage plans are generally required to cover services equivalent to traditional Medicare, they possess considerable latitude in establishing their own provider networks and setting specific coverage criteria within federal guidelines. Consequently, a Medicare Advantage member whose current RPM program depends on contracted staff could face significant changes if the CMS proposal is finalized as written.
The impetus behind CMS’s proposed crackdown stems from a growing body of evidence indicating potential issues within the RPM landscape. A 2024 report from the HHS Office of Inspector General (OIG) highlighted that approximately 43% of Medicare enrollees receiving RPM services did not receive all three essential components of the service: device setup and education, the provision of the monitoring device itself, and ongoing treatment management by a clinician. This suggests a gap between the services billed and those actually delivered.
The utilization of RPM has experienced a meteoric rise in recent years. Data from a 2025 follow-up study indicated a substantial 31% increase in Medicare payments for these services, escalating from $408 million in 2023 to $536 million in 2024. During this period, nearly one million enrollees received RPM services in 2024, underscoring its expanding role in patient care.
These findings point towards potential billing inefficiencies or gaps, rather than outright fraud in every instance. Some physician groups contend that missing components may be a reflection of how services were coded and billed, rather than an indication that care was not delivered. While research unequivocally supports the benefits of RPM for specific conditions, particularly heart failure, there remains a notable absence of studies directly comparing patient outcomes under RPM programs managed by directly employed staff versus those utilizing contracted personnel.
For current beneficiaries, there is no immediate change to their RPM services. Patients utilizing home monitoring devices are advised to continue their regimen as directed and submit readings as usual. The CMS proposal is still in its preliminary stages, and the agency typically releases its final physician payment rule in early November.
As the Medicare open enrollment period approaches, beneficiaries are strongly encouraged to take proactive steps. It is crucial to inquire with both the Medicare Advantage plan and the specific doctor’s office managing the monitoring program about how RPM services are delivered – whether through the practice’s own staff or an external company – and whether any changes are anticipated in 2027. Comparing plans on Medicare.gov or by contacting 1-800-MEDICARE can provide clarity on how different plans cover RPM for specific health conditions.
Vigilance against potential scams is also paramount. Beneficiaries should carefully review their Medicare statements for any unfamiliar monitoring charges and exercise caution by not sharing their Medicare numbers with unsolicited callers. It is also vital to understand that in case of critical health readings, immediate emergency care is necessary. For instance, a dangerously high blood pressure reading accompanied by chest pain, severe headache, confusion, or unilateral weakness requires urgent medical attention. Similarly, sudden weight gain or worsening shortness of breath in individuals with heart failure warrants prompt contact with a healthcare provider, rather than waiting for a monitoring team to initiate contact.
Key Questions Answered:
- What is Medicare proposing? Starting January 1, 2027, Medicare would only reimburse for remote monitoring services when performed by clinical staff directly employed by the billing practice, excluding services from outside contractors.
- Which insurers oppose the plan? UnitedHealth Group, CVS Health, and Kaiser Permanente have formally expressed their opposition to CMS. Humana and the Blue Cross Blue Shield Association support the proposal.
- Why do insurers disagree? Companies with substantial employed care networks, such as CVS and Kaiser, argue that the rule would disrupt their integrated care models. CVS has suggested that Medicare should focus on establishing vendor standards instead of a ban.
- Why did CMS propose the change? CMS cited findings from a federal watchdog report indicating that approximately 43% of Medicare enrollees did not receive all components of remote monitoring services. Rapid growth in spending for these services was also a factor.
- Will my home monitoring stop? Not at present. The rule is still a proposal, and any changes would not take effect until 2027, if finalized.
- What should Medicare Advantage members do? Medicare Advantage members should proactively ask their plan and their monitoring provider about how services are delivered and whether changes are expected. They should also compare coverage options during open enrollment and carefully review their Medicare statements for any discrepancies.
